In order to stay informed about the latest RBM trends, visit RBM-relevant conferences. What RBM-relevant conferences are coming in 2016-2017? For your convenience, please, see below an event calendar with the major RBM conferences. Enjoy! (The direct link to the calendar is here.) [...]
J. Proeve, Ph.D., an expert with 35+ years of experience as Global Data Management Head at Bayer started this week as Chief Scientific Officer at Cyntegrity. He takes the responsibility of building up a proper Risk-based Monitoring (RBM) strategy for each clinical study and develop further Cyntegrity's core product RBM [...]
What are the most common risks in clinical trials? What challenges faces TransCelerate RACT? Read the answers in the latest article published on ACT. by Moe Alsumidaie, Beat Widler, PhD, Peter Schiemann, PhD, Artem Andrianov, PhD Do you want to know about @RACT more and start [...]
What is the formula of clinical trial success? Performance is hard to sustain and risks are emerging unexpectedly. The goal of this article is to define a robust methodology for managing performance and risk in clinical trials. by Dimitri Stamatiadis, PhD, MBA Why measure performance? You [...]
The majority of companies are delaying the RBM adoption. Why? The reason lies now in the nature of innovation adoption. The main hesitations of the pragmatists to apply RBM nowadays are connected with: the general complexity of the approach the perceived risk of audit findings [...]
Dear Friends! Do you wish to witness the ground-shaking and revolutionary inventions in the area of clinical trial management? Innovations that make clinical performance control, fraud detection, data integrity, and risk evaluation easy and effective? Design your own cockpit of a clinical trial together with us and [...]
01.04.2016. Cyntegrity, cloud solution service provider for the efficient Risk-based Monitoring (RBM) of a clinical trial, is pleased to announce its partnership with Metrics Champion Consortium (MCC). MCC is the thought leader in providing metrics for the clinical trials industry offering qualitative and quantitative [...]
Interview with Artem Andrianov during PCT 2015: What Pharma Gains from Structured RBM?
What SDV is really for? How it develops and to what form it evolves? What is the future role of a CRA? This article depicts a role of SDV in a clinical monitoring process, shows the path of [...]
In the nearest week-end Cyntegrity migrates all its Risk-based Monitoring services to one unified address: RBM.Cloud. The CRO oversight services will be later migrated to: CRO.Cloud.
